If you are a consultant pharmacist stepping into skilled nursing / long-term care (SNF) work, or a Director of Nursing (DON) or administrator evaluating what a pharmacy consultant actually delivers, this guide lays out the role in practical terms. You will get the core duties, the regulatory backdrop, and the workflow a modern consultant pharmacist follows in a skilled nursing facility.
The consultant pharmacist role in a skilled nursing facility
A consultant pharmacist in a skilled nursing facility is the clinical reviewer who evaluates each resident's medication regimen, surfaces potential problems, and communicates recommendations to the prescriber and facility team. This is distinct from the dispensing pharmacist. The consultant's job is oversight, review, and documentation, not filling prescriptions.
Federal requirements for long-term care facilities call for the drug regimen of each resident to be reviewed at least monthly by a licensed pharmacist, with irregularities reported to the attending physician and the medical director or director of nursing. The exact obligations, survey expectations, and associated F-tags are defined by the Centers for Medicare & Medicaid Services (CMS), and they are periodically updated, so always confirm the current language at the official source.
For authoritative requirements, consult the CMS long-term care regulations and State Operations Manual guidance at cms.gov. State boards of pharmacy also impose their own consultant pharmacist requirements, which vary.
The medication regimen review (MRR): the heart of the job
The medication regimen review (MRR) is the recurring clinical task that anchors the consultant pharmacist's month. During an MRR, the pharmacist examines each resident's active medications against the clinical picture available in the chart and applies professional judgment to identify potential concerns.
Common categories a consultant pharmacist evaluates during an MRR include:
- Potentially inappropriate medications in older adults, such as those flagged by the American Geriatrics Society (AGS) Beers Criteria.
- Potentially inappropriate prescribing and prescribing omissions using STOPP/START (Screening Tool of Older Persons' Prescriptions / Screening Tool to Alert to Right Treatment) criteria.
- Cumulative anticholinergic burden (ACB), where multiple medications with anticholinergic properties add up to meaningful risk.
- Opportunities for gradual dose reduction (GDR) of psychotropic medications, evaluated in the context of behavioral health monitoring and documentation.
- Duplicate therapy, drug-drug interactions, and monitoring gaps.
- Indications that appear undocumented, or durations that appear to exceed what the record supports.
Importantly, these criteria are decision-support tools, not mandates. The consultant pharmacist weighs each flag against the individual resident's goals of care, diagnoses, and clinical context, then frames a recommendation for the prescriber to accept or decline. Nothing here is patient-specific clinical or dosing advice; it is the general framework a licensed pharmacist applies with judgment.
Antipsychotics, GDRs, and unnecessary drug scrutiny
CMS has long placed heightened scrutiny on antipsychotic use and on "unnecessary drugs" in long-term care. Consultant pharmacists play a central role here by evaluating whether a psychotropic medication has an adequate indication, whether monitoring is documented, and whether a gradual dose reduction has been attempted or clinically contraindicated.
The goal is not blanket discontinuation. It is ensuring that each medication has a documented rationale and that reduction attempts are considered where appropriate. The consultant documents the clinical reasoning so the facility can demonstrate a defensible process during survey.
Beyond the monthly review: the consultant's broader duties
A consultant pharmacist in a skilled nursing facility does more than the monthly MRR. Depending on the contract and state requirements, the role often includes:
- Medication storage and disposal oversight — inspecting medication rooms and carts for security, labeling, expiration, and controlled-substance handling.
- Policy and procedure input — helping the facility align medication-related policies with current standards.
- Support for CMS core elements of antibiotic stewardship — contributing pharmacy expertise to the facility's stewardship program.
- Quality assurance and performance improvement (QAPI) participation — bringing medication-safety data to the table.
- Education — briefing nursing and prescribing staff on high-risk medication practices.
These duties turn the consultant pharmacist into a standing safety partner rather than a once-a-month visitor. Learn how these workflows come together in the SNF / long-term care solution.
What a consultant pharmacist actually produces
The deliverables matter as much as the review itself, because they are what the facility relies on during survey and what the prescriber acts on. A consultant pharmacist typically produces:
- Written recommendations tied to each identified irregularity, with clinical rationale.
- A record of prescriber responses (accepted, declined, or modified) and the reasoning.
- Signed review documentation showing the monthly MRR was completed for each resident.
- Reports and summaries the facility can present to surveyors and its QAPI committee.
The signature and the audit trail are not clerical afterthoughts. They are the evidence that the required review happened, by a licensed pharmacist, on time, with follow-through.
A practical monthly workflow
Consultant pharmacists differ in style, but a reliable monthly cadence usually looks like this:
- Gather the chart data — active medication list, diagnoses, recent labs, and relevant monitoring for each resident.
- Screen against criteria — apply Beers, STOPP/START, anticholinergic burden, and duplicate-therapy checks to flag candidates for closer review.
- Apply clinical judgment — separate true concerns from expected, well-documented therapy for that individual.
- Draft recommendations — write clear, prescriber-ready notes with rationale.
- Communicate and route — send irregularities to the attending physician and notify the medical director or DON as required.
- Track responses and sign off — capture the outcome, complete documentation, and close the loop.
- Bundle for the facility — deliver reports for survey readiness and QAPI review.
The bottleneck is rarely clinical skill. It is the volume of chart data to comb through and the manual assembly of documentation across many residents each month. That is where tooling changes the economics of the practice. See how the clinical engine and report bundles fit together on the features page.
How WeConsultRx helps
WeConsultRx gives consultant pharmacists AI-assisted SNF chart review built on codified clinical rule packs aligned to American Society of Consultant Pharmacists (ASCP) practice, the AGS Beers Criteria, and STOPP/START. The platform surfaces potential irregularities for your review, keeps you in control of every clinical decision and e-signature, and assembles the signed recommendations and audit trail into survey-ready report bundles. You stay the clinician; the software removes the manual chart-combing and report assembly. Request a demo to see the SNF workflow end to end.